| 5.93 0.12 (2.07%) | 06-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 18.97 | 1-year : | 27.79 |
| Resists | First : | 16.24 | Second : | 23.79 |
| Pivot price | 5.81 |
|||
| Supports | First : | 4.01 | Second : | 3.34 |
| MAs | MA(5) : | 7.03 |
MA(20) : | 5.67 |
| MA(100) : | 5.48  |
MA(250) : | 23.4 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 19.6 |
D(3) : | 27.5 |
| RSI | RSI(14): 50.7 |
|||
| 52-week | High : | 89.91 | Low : | 3.38 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ NXTS ] has closed below upper band by 48.6%. Bollinger Bands are 195.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 6.44 - 6.48 | 6.48 - 6.52 |
| Low: | 5.48 - 5.52 | 5.52 - 5.55 |
| Close: | 5.87 - 5.94 | 5.94 - 5.99 |
N2OFF, Inc. operates as a clean technology firm dedicated to pioneering sustainable energy solutions and advanced agricultural innovations. The company delivers integrated approaches for renewable energy generation, reducing greenhouse gas emissions, and enhancing safety and quality within the agri-tech sector. Its key offerings include SpuDefender, designed to manage post-harvest potato sprouting, and FreshProtect, which targets spoilage-inducing microorganisms on citrus fruits after harvesting. N2OFF structures its business around two primary divisions: pathogen prevention and shelf-life enhancement, and global warming solutions specifically addressing N2O emissions. Founded by Nimrod Ben-Yehuda on April 1, 2009, N2OFF is headquartered in Neve Yarak, Israel.
Sun, 21 Jun 2026
N2OFF Ord Shs (NXTS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Wed, 17 Jun 2026
N2OFF Ord Shs (NXTS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Wed, 17 Jun 2026
N2OFF Ord Shs (NXTS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Wed, 17 Jun 2026
N2OFF Ord Shs (NXTS) Institutional Confidence - TradingKey
Wed, 17 Jun 2026
N2OFF Ord Shs (NXTS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Wed, 17 Jun 2026
N2OFF Ord Shs (NXTS) Valuation: PE, PB & Fair Value Analysis - TradingKey
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 1 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 45 (%) |
| Held by Institutions | 2.2 (%) |
| Shares Short | 25 (K) |
| Shares Short P.Month | 23 (K) |
| EPS | -17.52 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 17.76 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -37.6 % |
| Return on Equity (ttm) | -119.7 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -9.57 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -4 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -0.34 |
| PEG Ratio | 0 |
| Price to Book value | 0.33 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.99 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|